Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam study

Archives of Neurology

Volumn 55, Issue 7, 1998, Pages 964-968

  Slooter, Arjen J C ^a   Cruts, Marc ^b   Kalmijn, Sandra ^a   Hofman, Albert ^a   Breteler, Monique M B ^a   Van Broeckhoven, Christine ^b   Van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DNA;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; RISK ASSESSMENT;

EID: 0031839545     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.7.964     Document Type: Article

References (29)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
2. van Duijn CM, De Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994;7:74-78.
3. Jarvik GP, Larson EB, Goddard K, Kukull WA, Schellenberg GD, Wijsman EM. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet. 1996;58:191-200.
4. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele e4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387-1390.
5. Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E ∈4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997; 277:822-824.
6. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E ∈4 association with dementia in a population-based study: The Framingham Study. Neurology. 1996; 46:673-677.
7. Bickeböller H, Campion D, Brice A, et al. Apolipoprotein E and Alzheimer: genotype-specific risks by age and sex. Am J Hum Genet. 1997;60:439-446.
8. Tsuang D, Kukull W, Sheppard L, et al. Impact of sample selection on APOE ∈4 allele frequency: a comparison of two Alzheimer's disease samples. J Am Geriatr Soc. 1996;44:704-707.
9. Mullan M, Scibelli P, Duara R, et al. Familial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann N Y Acad Sci. 1996;802:16-26.
10. Stern Y, Brandt J, Albert M, et al. The absence of an apolipoprotein ∈4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol. 1997; 41:615-620.
11. van Duijn CM, De Knijff P, Wehnert A, et al. The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol. 1995;37:605-610.
12. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onsetAlzheimer disease. Nat Genet. 1994;7:180-184.
13. Zubenko GS, Stiffler S, Stabler S, et al. Association of the apolipoprotein E ∈4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet. 1994;54:199-205.
14. Hofman A, Grobbee DE, De Jong PTVM, Van den Ouweland FA. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol. 1991;7:403-422.
15. Ott A, Breteler MM, Van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education: The Rotterdam Study. BMJ. 1995;310:970-973.
16. Ott A, Breteler MMB, Van Harskamp F, Stijnen T, Hofman A. The incidence and risk of dementia: The Rotterdam Study. Am J Epidemiol. 1998;147:574-580.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
19. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
20. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
21. Hennekens CH, Buring JE. Measures of disease frequency. In: Mayrent SL, ed. Epidemiology in Medicine. Boston, Mass: Little Brown & Co Inc; 1987:90-93.
22. Altman DG. Multiple regression. In: Practical Statistics for Medical Research. London, England: Chapman & Hall; 1991:345-346.
23. Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E ∈4 allele and lifetime risk of Alzheimer's disease: what physicians know, and what they should know. Arch Neurol. 1995;52:1074-1079.
24. Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol. 1994;51:888-895.
25. Slooter AJC, Tang MX, van Duijn CM, et al. Apolipoprotein E ∈4 and the risk of dementia with stroke: a population-based investigation. JAMA. 1997;277: 818-821.
26. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet. 1996;58:803-811.
27. Reilly SL, Ferrell RE, Kottke BA, et al. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN, I: pleiotropic effects on means and variances. Am J Hum Genet. 1991;49:1155-1166.
28. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA. 1995;274:1627-1629.
29. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet. 1996;347:1091-1095.